Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Evans

Showing results (151-160 of 208) with videos related to

Pageof 21
Sort By:
JACC. Cardiooncology|August 16, 2021
Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer: The PRONOUNCE Trial Study DesignChiara Melloni, Susan F Slovin, Allan Blemings, et al.
Oncogene|July 17, 2021
ARVib suppresses growth of advanced prostate cancer via inhibition of androgen receptor signalingChengfei Liu, Cameron M Armstrong, Shu Ning, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2014
Chem-seq permits identification of genomic targets of drugs against androgen receptor regulation selected by functional phenotypic screensChunyu Jin, Liuqing Yang, Min Xie, et al.
Plos One|April 6, 2012
MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growthNagalakshmi Nadiminty, Ramakumar Tummala, Wei Lou, et al.
Oncogene|April 10, 2025
Correction: Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancerJoy C Yang, Pengfei Xu, Shu Ning, et al.
Oncogene|January 3, 2023
Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancerJoy C Yang, Pengfei Xu, Shu Ning, et al.
Genes & Cancer|September 3, 2010
Autophagy Blockade Sensitizes Prostate Cancer Cells towards Src Family Kinase InhibitorsZhaoju Wu, Pei-Ching Chang, Joy C Yang, et al.
Nature Communications|November 18, 2018
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancerChengfei Liu, Wei Lou, Joy C Yang, et al.
Communications Medicine|September 26, 2022
Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomesShu Ning, Jinge Zhao, Alan P Lombard, et al.
Prostate Cancer and Prostatic Diseases|November 21, 2019
Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancerWilliam S Chen, Eric L Feng, Rahul Aggarwal, et al.
Pageof 21

Showing results (151-160 of 208) with videos related to

Sort By:
Pageof 21
JACC. Cardiooncology|August 16, 2021
Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer: The PRONOUNCE Trial Study DesignChiara Melloni, Susan F Slovin, Allan Blemings, et al.
Oncogene|July 17, 2021
ARVib suppresses growth of advanced prostate cancer via inhibition of androgen receptor signalingChengfei Liu, Cameron M Armstrong, Shu Ning, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2014
Chem-seq permits identification of genomic targets of drugs against androgen receptor regulation selected by functional phenotypic screensChunyu Jin, Liuqing Yang, Min Xie, et al.
Plos One|April 6, 2012
MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growthNagalakshmi Nadiminty, Ramakumar Tummala, Wei Lou, et al.
Oncogene|April 10, 2025
Correction: Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancerJoy C Yang, Pengfei Xu, Shu Ning, et al.
Oncogene|January 3, 2023
Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancerJoy C Yang, Pengfei Xu, Shu Ning, et al.
Genes & Cancer|September 3, 2010
Autophagy Blockade Sensitizes Prostate Cancer Cells towards Src Family Kinase InhibitorsZhaoju Wu, Pei-Ching Chang, Joy C Yang, et al.
Nature Communications|November 18, 2018
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancerChengfei Liu, Wei Lou, Joy C Yang, et al.
Communications Medicine|September 26, 2022
Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomesShu Ning, Jinge Zhao, Alan P Lombard, et al.
Prostate Cancer and Prostatic Diseases|November 21, 2019
Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancerWilliam S Chen, Eric L Feng, Rahul Aggarwal, et al.
Pageof 21